Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: HB who wrote (241)	2/6/1998 3:45:00 AM
From: hillary kapan	Read Replies (2) \| Respond to of 4474

Greetings Howard, I think it is more than decent. The market cap for this world class research team plus sound management is absurd. The cap is less than what big pharma is/has been willing to pay for some of the pieces. Granted, there may be some horrendous news about to hit. That's the only thing that could explain the action of the market other than sheer irrationality. If that news did hit, then I would average down. I haven't checked the ratio of market cap to cumulative research spending lately, but it has got to be pretty stunning as well. Cheers, Hillary